Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis
about
Ovarian cancer, the coagulation pathway, and inflammationPAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasisEndometriosis, angiogenesis and tissue factorProteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic CancerGranzyme K activates protease-activated receptor-1Regulatory network of inflammation downstream of proteinase-activated receptorsRole of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surfaceTissue factor and PAR2 signaling in the tumor microenvironmentTissue factor-factor VIIa signaling.Protease Inhibitors in Tick Saliva: The Role of Serpins and Cystatins in Tick-host-Pathogen Interaction.Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling.Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.Targeting tumor-associated macrophages as a novel strategy against breast cancer.Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducinsMDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cellsProteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functionsBlocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosisProtease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization.Protease-activated drug development.Protease-activated receptors in cancer: A systematic review.Clinical relevance of proteinase activated receptors (pars) in the gutProtease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.JDINAC: joint density-based non-parametric differential interaction network analysis and classification using high-dimensional sparse omics data.PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancerClinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway.Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivoThrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222Cofactoring and dimerization of proteinase-activated receptorsTissue factor in cancer progression and angiogenesis.Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration.Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impactProteinase-activated receptors differentially modulate in vitro invasion of human pancreatic adenocarcinoma PANC-1 cells in correlation with changes in the expression of CDC42 protein.Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma.
P2860
Q24816796-F47091D5-8727-4810-B1F4-6C1829A776FCQ27001552-651D16AB-1985-4E51-95CE-48E171AD6827Q27013803-C6DAACE2-EDA5-4AFF-9DEC-1A6DE45360B9Q28079318-97D17300-4CA8-412B-A7DE-DEFF23422BA2Q28743018-D047E5CC-B4B9-4958-AC8A-EE14A8D2F8EFQ33280659-E6FC132A-CB13-4F22-840D-6991D2ADA695Q33378232-AE711B76-3FDA-4DBA-8233-DC0289AD276DQ33585541-84B1B7E8-2E69-4943-AF98-1CD04D311287Q33592102-3341B18D-31DB-4C36-8FBA-0914B2E82CDEQ33726774-579A0A61-A73B-4299-9E50-DB15C73A9017Q33734766-4021FE30-800F-4927-A131-6914A78EA399Q33959220-0EAC894F-2123-4915-8D6E-A523898F1AE6Q34441622-08B96C82-F088-4341-90E2-2F365D5054E8Q34686193-21F5AA22-9E62-4E1C-A79A-2FD158FC9A99Q34803221-F2FE64E8-D2DD-4014-8DF5-E97144817E8EQ35002854-130BED32-4F45-4622-ACE1-F1842BE3BBB2Q35055504-2A952E65-1F82-4BFD-9694-34306B4723A0Q35150513-73F4BDBD-0A52-4B24-B330-20C77820643EQ35151497-AC77C0A9-B44B-4B50-A843-89D3BEBF51B4Q35695573-4BDDD155-F3FF-446E-8A10-DAABC6A46986Q35720592-7909D713-B061-40CD-B510-7B0FC3B00C6EQ35811508-B0913F9D-7467-4CE8-9B53-D08A1C36D2C0Q36121203-F27457BC-EA71-4648-A494-CB1BFD950B05Q36124432-3C4FAB09-8DE5-46E2-8700-57F06F4004D8Q36322931-5ABC3D21-AC37-4C8A-AFFD-E45482B8E242Q36393065-9EC9765C-3ECA-4C22-87B9-2B391692B9BEQ36493144-B7548169-F6F1-4571-BC44-F3C000509FB1Q36627182-4BEB4755-5FA3-40D6-A829-BFBE48AE597FQ36814799-8DCCBA30-D9F8-4F5F-8098-042E3B8D8328Q37000605-4E9F941E-31D9-4BB6-9509-E303A16192CBQ37019583-244BDEC8-4D14-4E15-8C12-161CE65E25BAQ37138893-4C213036-A63F-44B1-89B4-76C5FD8257B0Q37188430-3DB31BE6-022D-4555-944E-71BC63603F4AQ37236116-1C27DF11-9DED-4A49-9DCA-C929D7758D7AQ37308155-DBB9FE55-9DF3-4E32-B803-EEB9FDA70D3EQ37312105-75C1F807-F176-4F7B-B235-8079A95B8AC9Q37323621-CFFC03BE-38B5-4441-BAE8-59EAC813D32DQ37348262-E33B13FA-8BF2-49FF-A583-3D711DE73994Q37350958-052A39C3-3FF7-42C5-A520-E7939A0CF5A2Q37407113-E83D66DC-2CCE-4480-AC09-3028EA8D04E6
P2860
Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Protease-activated receptors ( ...... r cell motility and metastasis
@ast
Protease-activated receptors ( ...... r cell motility and metastasis
@en
Protease-activated receptors ( ...... r cell motility and metastasis
@nl
type
label
Protease-activated receptors ( ...... r cell motility and metastasis
@ast
Protease-activated receptors ( ...... r cell motility and metastasis
@en
Protease-activated receptors ( ...... r cell motility and metastasis
@nl
prefLabel
Protease-activated receptors ( ...... r cell motility and metastasis
@ast
Protease-activated receptors ( ...... r cell motility and metastasis
@en
Protease-activated receptors ( ...... r cell motility and metastasis
@nl
P2093
P3181
P1476
Protease-activated receptors ( ...... r cell motility and metastasis
@en
P2093
Barbara M Mueller
Beena Gangadharan
Lawrence F Brass
Wolfram Ruf
Xiaoli Shi
P304
P3181
P407
P577
2004-07-01T00:00:00Z